PAR 0.00% 29.0¢ paradigm biopharmaceuticals limited..

Ann: Voluntary Suspension, page-18

  1. 54 Posts.
    lightbulb Created with Sketch. 15
    As alluded to in another thread, there is a much larger P3 trial requirement. A second trial that will run in conjunction with the first. Over 1,000 participants in total.
    Primary and Secondary end points have been agreed to.
    WOMAC scores for SAS patients have been published.
    I don't think there is any funny business here - FDA minutes were provided to PAR, dictated a larger trial requirement, PAR want to make sure they are covered for the larger trial and OPEX for 2 years.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.0¢
Change
0.000(0.00%)
Mkt cap ! $103.1M
Open High Low Value Volume
28.5¢ 29.5¢ 28.5¢ $78.30K 269.1K

Buyers (Bids)

No. Vol. Price($)
2 12512 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.5¢ 689 3
View Market Depth
Last trade - 14.43pm 08/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.